🔗 Share this article WHO Raises Warning Over Acute Scarcity of Weight-Loss Medications Less than 10% of people that would benefit from weight-loss injections including Wegovy can access them, warns the World Health Organization as it issues its inaugural advice on the drugs. With more than one billion individuals worldwide currently classified as obese, it is calling for broader and more equitable availability to this class of drugs. According to forecasts, in excess of 2,000,000,000 will be living with obesity by 2030 without intervention. "Our new guidelines recognises that obesity is a lifelong illness that can be managed with comprehensive and continuous treatment," stated the agency's head Tedros Adhanom Ghebreyesus. Substantial prices, limited production capacity, and distribution challenges are significant obstacles to universal availability to the jabs that can assist patients in reducing substantial weight, notes the agency. Skinny Jab Supply Crisis Despite the present most favorable scenario, the supply of such drugs might only reach approximately 100 million people – less than 10% of eligible patients, as stated by the health organization. The guideline calls on countries and companies to widen availability, via measures like patent sharing. The intellectual property rights on a key compound – the core ingredient of the drug Wegovy – is set to lapse in a number of nations in 2026. The Way Obesity Injections Operate These medications imitate a body's own hormone to delay gastric emptying, suppress the appetite and increase feelings of fullness so users consume fewer calories. Patients usually see weight reduction after several weeks of commencing the once-weekly jabs. Studies points to people may put most of the weight back on after a year of stopping the drug, as their typical food cravings resume. Being overweight or obese raises your chance for developing health problems, like diabetes, cardiovascular issues, stroke, and certain malignancies. Excess weight affects individuals in every country and was responsible for over three and a half million deaths worldwide in 2024, according to the health agency.
Less than 10% of people that would benefit from weight-loss injections including Wegovy can access them, warns the World Health Organization as it issues its inaugural advice on the drugs. With more than one billion individuals worldwide currently classified as obese, it is calling for broader and more equitable availability to this class of drugs. According to forecasts, in excess of 2,000,000,000 will be living with obesity by 2030 without intervention. "Our new guidelines recognises that obesity is a lifelong illness that can be managed with comprehensive and continuous treatment," stated the agency's head Tedros Adhanom Ghebreyesus. Substantial prices, limited production capacity, and distribution challenges are significant obstacles to universal availability to the jabs that can assist patients in reducing substantial weight, notes the agency. Skinny Jab Supply Crisis Despite the present most favorable scenario, the supply of such drugs might only reach approximately 100 million people – less than 10% of eligible patients, as stated by the health organization. The guideline calls on countries and companies to widen availability, via measures like patent sharing. The intellectual property rights on a key compound – the core ingredient of the drug Wegovy – is set to lapse in a number of nations in 2026. The Way Obesity Injections Operate These medications imitate a body's own hormone to delay gastric emptying, suppress the appetite and increase feelings of fullness so users consume fewer calories. Patients usually see weight reduction after several weeks of commencing the once-weekly jabs. Studies points to people may put most of the weight back on after a year of stopping the drug, as their typical food cravings resume. Being overweight or obese raises your chance for developing health problems, like diabetes, cardiovascular issues, stroke, and certain malignancies. Excess weight affects individuals in every country and was responsible for over three and a half million deaths worldwide in 2024, according to the health agency.